- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x 7T8: (3S,4R,4aR,6S,6aS,12R,12aS,12bS)-4-[(acetyloxy)methyl]-12-hydroxy-4,6a,12b-trimethyl-11-oxo-9-(pyridin-3-yl)-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-3,6-diyl diacetate(Non-covalent)
- 8 x CLR: CHOLESTEROL(Non-covalent)
CLR.2: 12 residues within 4Å:- Chain A: F.168, A.235, C.238, V.239, F.242, E.243, R.246, V.316, A.319, C.320, F.366, W.370
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:F.168, A:F.168, A:A.235, A:V.239, A:F.242, A:F.242, A:V.316, A:A.319, A:F.366, A:W.370
- Hydrogen bonds: A:R.246
CLR.3: 12 residues within 4Å:- Chain A: F.128, I.131, Y.132, F.135, I.136, C.315, L.360, F.364, W.390
- Chain B: H.127, T.130, I.131
12 PLIP interactions:10 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:F.128, A:I.131, A:Y.132, A:F.135, A:F.135, A:I.136, A:F.364, A:F.364, A:F.364, A:W.390, B:I.131
- Hydrogen bonds: B:H.127
CLR.6: 11 residues within 4Å:- Chain B: F.168, C.238, V.239, F.242, E.243, R.246, V.316, A.319, C.320, F.366, W.370
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:F.168, B:V.239, B:F.242, B:V.316, B:A.319, B:F.366, B:W.370
CLR.7: 12 residues within 4Å:- Chain A: H.127, T.130, I.131
- Chain B: F.128, I.131, Y.132, F.135, I.136, C.315, L.360, F.364, W.390
13 PLIP interactions:10 interactions with chain B, 3 interactions with chain A- Hydrophobic interactions: B:F.128, B:I.131, B:Y.132, B:F.135, B:F.135, B:I.136, B:F.364, B:F.364, B:F.364, B:W.390, A:I.131
- Hydrogen bonds: A:H.127, A:I.131
CLR.10: 12 residues within 4Å:- Chain C: F.168, A.235, C.238, V.239, F.242, E.243, R.246, V.316, A.319, C.320, F.366, W.370
11 PLIP interactions:11 interactions with chain C- Hydrophobic interactions: C:F.168, C:F.168, C:A.235, C:V.239, C:F.242, C:F.242, C:V.316, C:A.319, C:F.366, C:W.370
- Hydrogen bonds: C:R.246
CLR.11: 12 residues within 4Å:- Chain C: F.128, I.131, Y.132, F.135, I.136, C.315, L.360, F.364, W.390
- Chain D: H.127, T.130, I.131
12 PLIP interactions:2 interactions with chain D, 10 interactions with chain C- Hydrophobic interactions: D:I.131, C:F.128, C:I.131, C:Y.132, C:F.135, C:F.135, C:I.136, C:F.364, C:F.364, C:F.364, C:W.390
- Hydrogen bonds: D:H.127
CLR.14: 11 residues within 4Å:- Chain D: F.168, C.238, V.239, F.242, E.243, R.246, V.316, A.319, C.320, F.366, W.370
7 PLIP interactions:7 interactions with chain D- Hydrophobic interactions: D:F.168, D:V.239, D:F.242, D:V.316, D:A.319, D:F.366, D:W.370
CLR.15: 12 residues within 4Å:- Chain C: H.127, T.130, I.131
- Chain D: F.128, I.131, Y.132, F.135, I.136, C.315, L.360, F.364, W.390
12 PLIP interactions:10 interactions with chain D, 2 interactions with chain C- Hydrophobic interactions: D:F.128, D:I.131, D:Y.132, D:F.135, D:F.135, D:I.136, D:F.364, D:F.364, D:F.364, D:W.390, C:I.131
- Hydrogen bonds: C:H.127
- 4 x OLA: OLEIC ACID(Non-covalent)
OLA.4: 14 residues within 4Å:- Chain A: W.178, V.245, R.246, K.250, F.284, C.285, P.286, L.288, F.366, W.370, L.371, F.374, H.442, I.445
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:V.245, A:L.288, A:F.366, A:L.371, A:F.374, A:F.374, A:I.445
- Salt bridges: A:R.246
OLA.8: 14 residues within 4Å:- Chain B: W.178, V.245, R.246, K.250, F.284, C.285, P.286, L.288, F.366, W.370, L.371, F.374, H.442, I.445
9 PLIP interactions:9 interactions with chain B- Hydrophobic interactions: B:V.245, B:R.246, B:L.288, B:F.366, B:L.371, B:F.374, B:F.374, B:I.445
- Salt bridges: B:R.246
OLA.12: 14 residues within 4Å:- Chain C: W.178, V.245, R.246, K.250, F.284, C.285, P.286, L.288, F.366, W.370, L.371, F.374, H.442, I.445
8 PLIP interactions:8 interactions with chain C- Hydrophobic interactions: C:V.245, C:L.288, C:F.366, C:L.371, C:F.374, C:F.374, C:I.445
- Salt bridges: C:R.246
OLA.16: 14 residues within 4Å:- Chain D: W.178, V.245, R.246, K.250, F.284, C.285, P.286, L.288, F.366, W.370, L.371, F.374, H.442, I.445
9 PLIP interactions:9 interactions with chain D- Hydrophobic interactions: D:V.245, D:R.246, D:L.288, D:F.366, D:L.371, D:F.374, D:F.374, D:I.445
- Salt bridges: D:R.246
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Li, X. et al., Structure of PPPA bound human ACAT2. To Be Published
- Release Date
- 2021-09-22
- Peptides
- Sterol O-acyltransferase 2: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x 7T8: (3S,4R,4aR,6S,6aS,12R,12aS,12bS)-4-[(acetyloxy)methyl]-12-hydroxy-4,6a,12b-trimethyl-11-oxo-9-(pyridin-3-yl)-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-3,6-diyl diacetate(Non-covalent)
- 8 x CLR: CHOLESTEROL(Non-covalent)
- 4 x OLA: OLEIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Li, X. et al., Structure of PPPA bound human ACAT2. To Be Published
- Release Date
- 2021-09-22
- Peptides
- Sterol O-acyltransferase 2: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.